sintilizumab
1 abstract
Abstract
Efficacy and safety of anlotinib combined with sintilizumab in locally advanced or metastatic anaplastic thyroid carcinoma.Org: National Cancer Center Hospital East, Kashiwa, Japan, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, Academy of Medical Sciences & Peking Union Medical College, Beijing, China, Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,